Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Inotrem lève 39 millions d'euros pour combattre le choc septique | Les Echos
Roche cerrará planta en Estados Unidos
Leadership Team - Inotrem
Leadership Team - Inotrem
Roche unterzeichnet Vereinbarung zur Übernahme von Anadys Pharmaceuticals
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Inotrem, The French Biotech Firm Fighting Sepsis, COVID-19 And Other Acute and Chronic Inflammatory Diseases - Bpifrance.com
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Roche to Shut Down Former U.S. Headquarters, After 83 Years - The New York Times
PharmaBoardroom - Jean-Jacques Garaud - CEO, Inotrem, France
Roche, Inotrem extend collaboration on blood test for septic shock | Fierce Biotech
Chercheurs | Chaire Raoul-Dandurand en études stratégiques et diplomatiques | UQAM
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Roche Diagnostics s'allie à Inotrem contre le choc septique | Les Echos
Roche revamps research operations, cuts 1,000 U.S. jobs | Reuters
Roche picks Sanford-Burnham chief to revive lagging research group | Fierce Biotech
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Roche will close Nutley plant, shed nearly 1,000 jobs - nj.com
Swiss Drug Giant Roche to Cut 1,000 US Jobs and Close NJ Plant | Business Chief North America
Roche Pays Evotec $10M Up Front in Deal to Develop MAO-B Inhibitor for Alzheimer Disease
Anadys to be acquired by Roche in $230 mln deal | NASDAQ:ANDS
